
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL | 840 | 49.2% | -0.96 | 433 | 58.9% |
| CRE | 239 | 14.0% | -0.60 | 158 | 21.5% |
| CA | 245 | 14.4% | -3.94 | 16 | 2.2% |
| CentralBrain-unspecified | 147 | 8.6% | -1.47 | 53 | 7.2% |
| SLP | 71 | 4.2% | -2.56 | 12 | 1.6% |
| b'L | 35 | 2.1% | -0.27 | 29 | 3.9% |
| SCL | 46 | 2.7% | -2.94 | 6 | 0.8% |
| PED | 29 | 1.7% | -0.77 | 17 | 2.3% |
| PLP | 31 | 1.8% | -4.95 | 1 | 0.1% |
| LH | 16 | 0.9% | -4.00 | 1 | 0.1% |
| bL | 5 | 0.3% | 0.00 | 5 | 0.7% |
| LAL | 0 | 0.0% | inf | 3 | 0.4% |
| SMP | 1 | 0.1% | 0.00 | 1 | 0.1% |
| ICL | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg-s3 | % In | CV |
|---|---|---|---|---|---|
| KCg-d | 147 | DA | 193 | 24.3% | 1.1 |
| KCg-m | 176 | DA | 109 | 13.7% | 0.4 |
| VP3+VP1l_ivPN | 2 | ACh | 83 | 10.4% | 0.0 |
| PAM08 | 26 | DA | 59.5 | 7.5% | 1.1 |
| KCg-s2 | 2 | DA | 44 | 5.5% | 0.0 |
| PPL103 | 2 | DA | 38.5 | 4.8% | 0.0 |
| APL | 2 | GABA | 35.5 | 4.5% | 0.0 |
| LHPV3c1 | 2 | ACh | 25 | 3.1% | 0.0 |
| VP1d_il2PN | 2 | ACh | 18 | 2.3% | 0.0 |
| DPM | 2 | DA | 16 | 2.0% | 0.0 |
| VP1m_l2PN | 2 | ACh | 14 | 1.8% | 0.0 |
| KCg-s4 | 1 | DA | 13.5 | 1.7% | 0.0 |
| KCg-s1 | 2 | DA | 12.5 | 1.6% | 0.0 |
| PAM07 | 11 | DA | 11 | 1.4% | 0.7 |
| PAM05 | 7 | DA | 10.5 | 1.3% | 0.4 |
| LoVP51 | 1 | ACh | 7.5 | 0.9% | 0.0 |
| KCg | 1 | DA | 7.5 | 0.9% | 0.0 |
| VP1m+VP5_ilPN | 2 | ACh | 7.5 | 0.9% | 0.0 |
| PAM12 | 9 | DA | 7 | 0.9% | 0.4 |
| OA-VPM3 | 2 | OA | 6.5 | 0.8% | 0.0 |
| SLP360_b | 1 | ACh | 5.5 | 0.7% | 0.0 |
| KCa'b'-ap1 | 10 | DA | 5 | 0.6% | 0.0 |
| PPL101 | 2 | DA | 5 | 0.6% | 0.0 |
| MBON05 | 2 | Glu | 3.5 | 0.4% | 0.0 |
| PAM01 | 7 | DA | 3.5 | 0.4% | 0.0 |
| SMP146 | 2 | GABA | 3.5 | 0.4% | 0.0 |
| SLP360_a | 1 | ACh | 3 | 0.4% | 0.0 |
| M_lPNm13 | 3 | ACh | 3 | 0.4% | 0.1 |
| PAM02 | 2 | DA | 2.5 | 0.3% | 0.2 |
| MBON09 | 3 | GABA | 2.5 | 0.3% | 0.2 |
| KCab-p | 4 | DA | 2.5 | 0.3% | 0.2 |
| LHPV9b1 | 1 | Glu | 1.5 | 0.2% | 0.0 |
| SLP360_d | 1 | ACh | 1.5 | 0.2% | 0.0 |
| MBON32 | 1 | GABA | 1.5 | 0.2% | 0.0 |
| LHPV6k1 | 2 | Glu | 1.5 | 0.2% | 0.0 |
| OA-VPM4 | 2 | OA | 1.5 | 0.2% | 0.0 |
| LoVP38 | 1 | Glu | 1 | 0.1% | 0.0 |
| WED182 | 1 | ACh | 1 | 0.1% | 0.0 |
| VP1d+VP4_l2PN1 | 1 | ACh | 1 | 0.1% | 0.0 |
| PPL202 | 1 | DA | 1 | 0.1% | 0.0 |
| PFR_a | 2 | unc | 1 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 2 | OA | 1 | 0.1% | 0.0 |
| SLP438 | 2 | unc | 1 | 0.1% | 0.0 |
| MBON21 | 2 | ACh | 1 | 0.1% | 0.0 |
| CB0951 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| M_l2PNm16 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| CRE022 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| SLP080 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| PAM15 | 1 | DA | 0.5 | 0.1% | 0.0 |
| VP2+_adPN | 1 | ACh | 0.5 | 0.1% | 0.0 |
| KCab-s | 1 | DA | 0.5 | 0.1% | 0.0 |
| PLP171 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| M_lPNm11B | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LHPV2a1_d | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LHPV7c1 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LoVP67 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LoVP70 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| M_smPNm1 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| PPL102 | 1 | DA | 0.5 | 0.1% | 0.0 |
| WEDPN12 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| LHCENT4 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| CL357 | 1 | unc | 0.5 | 0.1% | 0.0 |
| MBON11 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LHPV12a1 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| DNp30 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| LoVCLo3 | 1 | OA | 0.5 | 0.1% | 0.0 |
| SMP075 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| CRE027 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| MBON33 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| SMP145 | 1 | unc | 0.5 | 0.1% | 0.0 |
| VP5+Z_adPN | 1 | ACh | 0.5 | 0.1% | 0.0 |
| CB4155 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| PAM06 | 1 | DA | 0.5 | 0.1% | 0.0 |
| SLP360_c | 1 | ACh | 0.5 | 0.1% | 0.0 |
| M_l2PNm17 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| M_lPNm11D | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LHPV2a1_a | 1 | GABA | 0.5 | 0.1% | 0.0 |
| MB-C1 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| VP1m+_lvPN | 1 | Glu | 0.5 | 0.1% | 0.0 |
| CRE048 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| LHAV3f1 | 1 | Glu | 0.5 | 0.1% | 0.0 |
| LAL100 | 1 | GABA | 0.5 | 0.1% | 0.0 |
| PPL201 | 1 | DA | 0.5 | 0.1% | 0.0 |
| MBON26 | 1 | ACh | 0.5 | 0.1% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 0.5 | 0.1% | 0.0 |
| downstream partner | # | NT | conns KCg-s3 | % Out | CV |
|---|---|---|---|---|---|
| KCg-d | 144 | DA | 186 | 18.5% | 1.0 |
| KCg-m | 216 | DA | 138.5 | 13.8% | 0.4 |
| PAM08 | 34 | DA | 79 | 7.9% | 1.1 |
| MBON05 | 2 | Glu | 57 | 5.7% | 0.0 |
| MBON09 | 4 | GABA | 42 | 4.2% | 0.0 |
| APL | 2 | GABA | 40.5 | 4.0% | 0.0 |
| KCg-s2 | 2 | DA | 38 | 3.8% | 0.0 |
| DPM | 2 | DA | 36 | 3.6% | 0.0 |
| MBON26 | 2 | ACh | 28 | 2.8% | 0.0 |
| PAM07 | 13 | DA | 25 | 2.5% | 0.5 |
| MBON11 | 2 | GABA | 24.5 | 2.4% | 0.0 |
| MBON33 | 2 | ACh | 22.5 | 2.2% | 0.0 |
| PPL103 | 2 | DA | 18.5 | 1.8% | 0.0 |
| MBON32 | 2 | GABA | 12 | 1.2% | 0.0 |
| MBON35 | 2 | ACh | 12 | 1.2% | 0.0 |
| KCg-s4 | 1 | DA | 11.5 | 1.1% | 0.0 |
| MBON04 | 2 | Glu | 11.5 | 1.1% | 0.0 |
| PPL101 | 2 | DA | 10.5 | 1.0% | 0.0 |
| MBON21 | 2 | ACh | 10.5 | 1.0% | 0.0 |
| PAM12 | 8 | DA | 10.5 | 1.0% | 0.6 |
| KCg-s1 | 2 | DA | 10 | 1.0% | 0.0 |
| KCg | 1 | DA | 9.5 | 0.9% | 0.0 |
| CRE048 | 2 | Glu | 8 | 0.8% | 0.0 |
| KCab-p | 12 | DA | 7.5 | 0.7% | 0.2 |
| MBON29 | 2 | ACh | 7.5 | 0.7% | 0.0 |
| CRE200m | 3 | Glu | 7 | 0.7% | 0.4 |
| MBON22 | 2 | ACh | 7 | 0.7% | 0.0 |
| PAM01 | 7 | DA | 7 | 0.7% | 0.2 |
| MBON27 | 2 | ACh | 6.5 | 0.6% | 0.0 |
| MBON01 | 1 | Glu | 6 | 0.6% | 0.0 |
| CRE080_c | 2 | ACh | 6 | 0.6% | 0.0 |
| LAL159 | 1 | ACh | 5 | 0.5% | 0.0 |
| KCa'b'-ap1 | 10 | DA | 5 | 0.5% | 0.0 |
| PPL104 | 2 | DA | 4.5 | 0.4% | 0.0 |
| PAM05 | 7 | DA | 4.5 | 0.4% | 0.3 |
| CRE080_d | 2 | ACh | 4.5 | 0.4% | 0.0 |
| OA-VPM4 | 2 | OA | 4 | 0.4% | 0.0 |
| SMP376 | 2 | Glu | 4 | 0.4% | 0.0 |
| LHPV3c1 | 2 | ACh | 3 | 0.3% | 0.0 |
| PPL202 | 1 | DA | 2.5 | 0.2% | 0.0 |
| MBON30 | 1 | Glu | 2.5 | 0.2% | 0.0 |
| CRE040 | 2 | GABA | 2.5 | 0.2% | 0.0 |
| FB4K | 2 | Glu | 2.5 | 0.2% | 0.0 |
| PAM02 | 3 | DA | 2.5 | 0.2% | 0.2 |
| CRE100 | 2 | GABA | 2 | 0.2% | 0.0 |
| PPL102 | 2 | DA | 2 | 0.2% | 0.0 |
| MBON12 | 1 | ACh | 1.5 | 0.1% | 0.0 |
| FB4C | 1 | Glu | 1.5 | 0.1% | 0.0 |
| LHPV7c1 | 1 | ACh | 1.5 | 0.1% | 0.0 |
| MBON31 | 1 | GABA | 1.5 | 0.1% | 0.0 |
| FB4Y | 2 | 5-HT | 1.5 | 0.1% | 0.3 |
| aMe26 | 1 | ACh | 1.5 | 0.1% | 0.0 |
| VP1m+VP5_ilPN | 1 | ACh | 1.5 | 0.1% | 0.0 |
| CRE105 | 2 | ACh | 1.5 | 0.1% | 0.0 |
| CRE049 | 2 | ACh | 1.5 | 0.1% | 0.0 |
| FB4R | 3 | Glu | 1.5 | 0.1% | 0.0 |
| SMP049 | 1 | GABA | 1 | 0.1% | 0.0 |
| SMP114 | 1 | Glu | 1 | 0.1% | 0.0 |
| PAM15 | 1 | DA | 1 | 0.1% | 0.0 |
| CRE080_a | 1 | ACh | 1 | 0.1% | 0.0 |
| LAL002 | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE021 | 1 | GABA | 1 | 0.1% | 0.0 |
| LoVC20 | 1 | GABA | 1 | 0.1% | 0.0 |
| OA-VPM3 | 1 | OA | 1 | 0.1% | 0.0 |
| SMP179 | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP146 | 1 | GABA | 1 | 0.1% | 0.0 |
| mALD3 | 1 | GABA | 1 | 0.1% | 0.0 |
| LAL198 | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE066 | 2 | ACh | 1 | 0.1% | 0.0 |
| CRE072 | 2 | ACh | 1 | 0.1% | 0.0 |
| KCa'b'-ap2 | 2 | DA | 1 | 0.1% | 0.0 |
| SMP075 | 2 | Glu | 1 | 0.1% | 0.0 |
| CRE067 | 2 | ACh | 1 | 0.1% | 0.0 |
| VP1m+VP2_lvPN2 | 2 | ACh | 1 | 0.1% | 0.0 |
| CRE044 | 2 | GABA | 1 | 0.1% | 0.0 |
| MBON20 | 2 | GABA | 1 | 0.1% | 0.0 |
| LHCENT3 | 2 | GABA | 1 | 0.1% | 0.0 |
| CRE023 | 2 | Glu | 1 | 0.1% | 0.0 |
| SLP461 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MBON03 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LHPV9b1 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CRE069 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CRE070 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB1699 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LHPD2a6 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| ATL035 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| ATL039 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CRE062 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| SLP360_a | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CRE027 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LHPV2a1_d | 1 | GABA | 0.5 | 0.0% | 0.0 |
| SLP473 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| VP3+VP1l_ivPN | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LHPV2a1_e | 1 | GABA | 0.5 | 0.0% | 0.0 |
| LAL101 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| FB5I | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LHAV3f1 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| PPL203 | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVP45 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LAL110 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LHPV1c2 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| PAM13 | 1 | DA | 0.5 | 0.0% | 0.0 |
| CRE081 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB1478 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CRE052 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| CRE043_c1 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| CRE003_b | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LHPV4c1_b | 1 | Glu | 0.5 | 0.0% | 0.0 |
| PFR_a | 1 | unc | 0.5 | 0.0% | 0.0 |
| CB0951 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CRE060 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB1454 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| VP1m+_lvPN | 1 | Glu | 0.5 | 0.0% | 0.0 |
| SMP116 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| IB115 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| SMP152 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.5 | 0.0% | 0.0 |
| SMP108 | 1 | ACh | 0.5 | 0.0% | 0.0 |